Thus, this cooperation between TCF1/LEF1 and ATF2 represents an unexpected new strategy used by tumor cells to aberrantly activate TCF1/LEF1 signaling independently of β-catenin and the Wnt canonical pathway. The gene discussed is LEF1; the disease is neoplasm.